Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies
Pediatric-onset multiple sclerosis (POMS) refers to multiple sclerosis occurring in individuals under 18 years of age. It is characterized by poor cognitive outcomes and a more inflammatory course, more frequent clinical relapses, and a greater number of MRI lesions compared to adult-onset MS (AOMS)...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2025-07-01
|
| Sarja: | Neurotherapeutics |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S1878747925001096 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|